{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-053849","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2026-08-06T11:33:12+00:00","discovered_at":"2026-08-06T11:35:00.319643+00:00","generated_at":"2026-08-06T11:35:16.400296+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Collegium Q2 net revenue $199.9M (+6% YoY); GAAP loss $0.46; guidance cut on total revenue and EBITDA","bullets":["Q2 net revenue $199.9M, up 6% YoY; GAAP net loss $15.1M ($0.46 loss per share) vs prior year net income $12.0M.","Non-GAAP adjusted net income $75.4M ($1.92 adj EPS); Adjusted EBITDA $113.8M, up 8% YoY.","JORNAY PM revenue $46.1M (+41% YoY); AZSTARYS revenue $12.9M (partial quarter after May 12 acquisition close).","Full-year 2026 guidance: Product Revenues $825-855M (down from $865-895M); AZSTARYS raised to $65-75M; Adjusted EBITDA $445-470M (down from $475-500M).","Completed acquisition of AZSTARYS from Corium Therapeutics; board appointed Michael Donovan; HQ relocation to Boston planned for Q1 2027."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-053849","json":"https://secwatch.observer/filing/0001628280-26-053849.json","markdown":"https://secwatch.observer/filing/0001628280-26-053849.md","text":"https://secwatch.observer/filing/0001628280-26-053849.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000162828026053849/0001628280-26-053849-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000162828026053849/coll-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:35:16.400296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}